Overview / Abstract: |
VTE is a common and potentially life-threatening complication in patients with cancer. This online activity reviews VTE pathophysiology, risk assessment, and supportive care interventions for ambulatory cancer patients. Venous thromboembolism (VTE) is a common and potentially life-threatening complication in patients with cancer. There are two main types of VTE: deep vein thrombosis (DVT) and pulmonary embolus (PE), which can cause right heart failure, cardiopulmonary collapse, and death (NCCN, 2021). Patients who develop PE require hospitalization, increased oxygen requirements, and the need for temporary and/or long-term anticoagulation. These complications, in turn, lead to delays in receipt of cancer therapy, an increased risk for VTE recurrence, increased risk of morbidity and mortality, decreased quality of life, and increased health care costs (Qdaisat et al, 2020; Chuang et al, 2019). Early identification of ambulatory chemotherapy patients at high risk for VTE will help the health care team to prescribe prophylaxis in a timely and appropriate manner, avoid use when inappropriate, and ultimately reduce the number of patients who experience VTE during their cancer treatment. TARGET AUDIENCE Nurses, nurse practitioners, and clinical nurse specialists. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: Describe pathophysiology of VTE |
Expiration |
Sep 21, 2023 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Credits / Hours |
1.0 CEU |
Accreditation |
ANCC |
Presenters / Authors / Faculty |
Lindsay Holden, RN, CCRN |
Keywords / Search Terms |
i3 Health i3 Health i3 Health oncology, Venous Thromboembolism, VTE, i3 Health, CNE, NCPD, free CNE, free NCPD Free CE CME Free CE CME Free CE CME |